Improving flap survival by transplantation of a VEGF-secreting endothelised scaffold during distal pedicle flap creation

Journal of Plastic, Reconstructive and Aesthetic Surgery

Volumn 60, Issue 3, 2007, Pages 279-286

  Lasso, J M ^a   Del Rio M ^b   Garcia M ^a   Martinez Calleja V ^c   Nava, P ^a   Munoz Fernandez M A ^a   Perez Cano R ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b CIEMAT   (Spain)

^c HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Adenovirus; Angiogenesis; Flaps; Gene therapy; VEGF

Indexed keywords

ADENOVIRUS VECTOR; CD31 ANTIGEN; CYCLOSPORIN A; FIBRIN; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA MODIFICATION; ENDOTHELIUM CELL; GRAFT PERFUSION; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PEDICLED SKIN FLAP; PRIORITY JOURNAL; PROTEIN SECRETION; RABBIT; SURVIVAL RATE; TISSUE ENGINEERING; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ANIMALS; ANTIGENS, CD31; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FIBRIN; GENE THERAPY; GENETIC VECTORS; GRAFT SURVIVAL; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; PEPTIDE FRAGMENTS; RABBITS; RECONSTRUCTIVE SURGICAL PROCEDURES; SKIN TRANSPLANTATION; SURGICAL FLAPS; TISSUE ENGINEERING; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33846872404     PISSN: 17486815     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bjps.2006.04.002     Document Type: Article

References (38)

1. Pang C.Y., Forrest C.R., and Morris S.F. Pharmacological augmentation of skin flap viability: a hypothesis to mimic the surgical delay phenomenon or a wishful thought. Ann Plast Surg 22 (1989) 293-306
2. Waters L.M., Pearl R.M., and Macaulay R.M. A comparative analysis of the ability of five classes of pharmacological agents to augment skin flap survival in various models and species: an attempt to standardize skin flap research. Ann Plast Surg 23 (1989) 117-122
3. Davis R.E., Wachholz J.H., Jassir D., et al. Comparison of topical anti-ischemic agents in the salvage of failing random-pattern skin flaps in rats. Arch Facial Plast Surg 1 (1999) 27-32
4. Zhang F., Waller W., and Lineaweaver W.C. Growth factors and flap survival. Microsurgery 24 (2004) 162-167
5. Li Q.F., Reis E.D., Zhang W.X., et al. Accelerated flap prefabrication with vascular endothelial growth factor. J Reconst Microsurg 16 (2000) 45-50
6. Simman R., Craft C., and McKinney B. Improved survival of ischemic random skin flaps through the use of bone marrow nonhematopoietic stem cells and angiogenic growth factors. Ann Plast Surg 54 (2005) 546-552
7. O'Toole G., MacKenzie D., Lindeman R., et al. Vascular endothelial growth factor gene therapy in ischaemic rat skin flaps. Br J Plast Surg 55 (2002) 55-58
8. Waller W., Lee J., Zhang F., et al. Gene therapy in flap survival. Microsurgery 24 (2004) 168-173
9. Del Rio M., Larcher F., Meana A., et al. Nonviral transfer of genes to pig primary keratinocytes. Induction of angiogenesis by composite grafts overexpressing VEGF driven by a keratin promoter. Gene Ther 6 (1999) 1734-1741
10. Del Rio M., Sunkel C., Larcher F., et al. Antiproliferative effects of PCA-4230, a new antithrombotic drug, in vascular smooth muscle cells. Br J Pharmacol 120 (1997) 1360-1366
11. In: Walker R.H. (Ed). Technical manual (1993), American Association of Blood Banks, Bethesda, MD 728-730
12. Nall A.V., Brownlee R.E., Colvin C.P., et al. Transforming growth factor beta 1 improves wound healing and random flap survival in normal and irradiated rats. Arch Otolaryngol Head Neck Surg 122 (1996) 171-177
13. Seify H., Bilkay U., and Jones G. Improvement of TRAM flap viability using human VEGF induced angiogenesis: a comparative study of delay techniques. Plast Reconstr Surg 112 (2003) 1032-1039
14. Lineaweaver W.C., Lei M.P., Mustain W., et al. Vascular endothelium growth factor, surgical delay, and skin flap survival. Ann Surg 239 (2004) 866-873
15. Hom D.B., Baker S.R., Graham L.M., et al. Utilizing angiogenic agents to expedite the neovascularization process in skin flaps. Laryngoscope 98 (1998) 521-526
16. Ishiguro N., Yabe Y., Shimizu T., et al. Basic fibroblast growth factor has a beneficial effect on the viability of random skin flaps in rats. Ann Plast Surg 32 (1994) 356-360
17. Taub P.J., Silver L., and Weinberg H. Plastic surgical perspectives on vascular endothelial growing factor as gene therapy for angiogenesis. Plast Reconst Surg 105 (2000) 1034-1041
18. Ashrafpour H., Huang N., Neligan P.C., et al. Vasodilator effect and mechanism of action of vascular endothelial growth factor in skin vasculature. Am J Physiol Heart Circ Physiol 286 (2004) H946-H954
19. Roberts W.G., and Palade G. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 108 (1995) 2369-2379
20. Zhang F., Lei M.P., Oswald T.M., et al. The effect of vascular endothelial growth factor on the healing of ischaemic skin wounds. Br J Plast Surg 56 (2003) 334-341
21. Lewis J.S., Landers R.J., Underwood J.C., et al. Expression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularized areas of breast carcinoma. J Pathol 192 (2000) 150-158
22. Akagi K., Ikeda Y., Miyakazi M., et al. Vascular endothelial growth factor-C, expression in human colorectal cancer tissues. Br J Cancer 83 (2000) 887-891
23. Sawano A., Sakurai I.S., Shitara I.M., et al. Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocytemacrophages in humans. Blood 97 (2001) 785-791
24. Padubidri A., and Browne E. Effect of vascular endothelial growth factor on survival of random extension of axial pattern skin flaps in the rat. Ann Plast Surg 37 (1996) 604-611
25. Taub P.J., Jonathan D.M., Zhang W.X., et al. Locally administered vascular endothelial growth factor cDNA increases survival of ischemic experimental skin flaps. Plast Reconst Surg 102 (1998) 2033-2039
26. Zhang F., Fischer K., Komorowska-Timek E., et al. Improvement of skin paddle survival by application of vascular endothelial growth factor in a rat TRAM flap model. Ann Plast Surg 46 (2001) 314-319
27. Banbury J., Semionov M., Porvasnik S., et al. Improved perfusion after subcritical ischemia in muscle flaps treated with vascular endothelial growth factor. Plast Reconstr Surg 106 (2000) 1541-1546
28. Pu L.Q., Gadowski G.R., Graham A.M., et al. Enhanced revascularization after angiogenic stimulation in a rabbit model of bilateral limb isquemia. Eur J Vasc Endovasc Surg 9 (1995) 189-196
29. Kryger Z., Zhang F., Dogan T., et al. The effects of VEGF on survival of a random flap in the rat: examination of various routes of administration. Br J Plast Surg 53 (2000) 234-239
30. Laitinen M., Makinen K., Manninen H., et al. Adenovirus mediated gene transfer to lower limb artery of patients with chronic critical leg ischemia. Hum Gene Ther 9 (1998) 1481-1486
31. 165 in patient with ischaemic limb. Lancet 348 (1996) 370-374
32. Ylä-Herttuala S. Vascular gene transfer. Curr Opin Lipidol 8 (1997) 72-76
33. Oligino T.J., Yao Q., Ghivizzani S.C., et al. Vectors for gene transfer to joints. Clin Orthop 379S (2000) S17-S30
34. 165 expressed by a replication-deficient recombinant adenovirus vector induces angiogenesis in vivo. Cir Res 77 (1995) 1077-1086
35. Sojeima K., Negishi N., Nozaki M., et al. Effect of cultured endothelial cells on angiogenesis in vivo. Plast Reconstr Surg 101 (1998) 1552-1560
36. Taran A., Har-Shai Y., Lindenbaum E., et al. Improved vitality of experimental random dorsal skin flaps in rats treated with enriched cell culture medium. Plast Reconstr Surg 104 (1999) 148-151
37. Rehman J., Traktuev D., Li J., et al. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 109 (2004) 1292-1298
38. Planat-Benard V., Silvestre J.S., Cousin B., et al. Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation 109 (2004) 656-663